Literature DB >> 12823958

Inverse agonism gains weight.

Roger A H Adan1, Martien J H Kas.   

Abstract

Inverse agonism is emerging as a new endogenous principle for receptor regulation. Agouti-related protein (AgRP), following its release in the brain, stimulates food intake. AgRP binds to brain melanocortin receptors, which are involved in the regulation of body weight. In addition to antagonizing the effects of the melanocortin receptor agonist alpha-melanocyte-stimulating hormone (alpha-MSH), AgRP suppresses the constitutive activity of melanocortin MC(3) and MC(4) receptors, which characterizes AgRP as an inverse agonist rather than a neutral antagonist. The balance between the activity of AgRP-containing neurons and alpha-MSH-containing neurons determines the extent of activation of melanocortin receptors in neurons onto which they project. The identification of AgRP as an endogenous inverse agonist provides physiological relevance to inverse agonism in the control of body weight.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12823958     DOI: 10.1016/S0165-6147(03)00130-5

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  14 in total

Review 1.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

Review 2.  Regulation of the oncoprotein Smoothened by small molecules.

Authors:  Hayley J Sharpe; Weiru Wang; Rami N Hannoush; Frederic J de Sauvage
Journal:  Nat Chem Biol       Date:  2015-04       Impact factor: 15.040

Review 3.  Neuroendocrine actions and regulation of hypothalamic neuropeptide Y during lactation.

Authors:  W R Crowley; G Ramoz; R Torto; K A Keefe; J J Wang; S P Kalra
Journal:  Peptides       Date:  2007-01-22       Impact factor: 3.750

4.  Loop-swapped chimeras of the agouti-related protein and the agouti signaling protein identify contacts required for melanocortin 1 receptor selectivity and antagonism.

Authors:  Mira P Patel; Camila S Cribb Fabersunne; Ying-Kui Yang; Christopher B Kaelin; Gregory S Barsh; Glenn L Millhauser
Journal:  J Mol Biol       Date:  2010-09-08       Impact factor: 5.469

5.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

Review 6.  Ghrelin receptor mutations--too little height and too much hunger.

Authors:  Birgitte Holst; Thue W Schwartz
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

7.  Mahogunin ring finger-1 (MGRN1) E3 ubiquitin ligase inhibits signaling from melanocortin receptor by competition with Galphas.

Authors:  Ana B Pérez-Oliva; Concepción Olivares; Celia Jiménez-Cervantes; José C García-Borrón
Journal:  J Biol Chem       Date:  2009-09-08       Impact factor: 5.157

8.  In silico mutagenesis: a case study of the melanocortin 4 receptor.

Authors:  Yana Bromberg; John Overton; Christian Vaisse; Rudolph L Leibel; Burkhard Rost
Journal:  FASEB J       Date:  2009-05-05       Impact factor: 5.191

Review 9.  GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism.

Authors:  Qi Wu; Richard D Palmiter
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

10.  Involvement of the V2 vasopressin receptor in adaptation to limited water supply.

Authors:  Iris Böselt; Holger Römpler; Thomas Hermsdorf; Doreen Thor; Wibke Busch; Angela Schulz; Torsten Schöneberg
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.